Chinese private equity targets record fundraisings - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
私募股权

Chinese private equity targets record fundraisings

Fast growing Boyu and Primavera join flurry of recent US dollar fund launches
00:00

{"text":[[{"start":15.16,"text":"Chinese private equity funds are targeting record fundraising this year as global investors boost their exposure to the country despite deep tensions with the US and heightened regulatory scrutiny of China’s technology groups. "}],[{"start":29.25,"text":"A group of fast-growing Chinese investment funds, which include Boyu Capital and Primavera Capital Group, have launched what are expected to be their largest-ever US dollar funds in recent weeks. "}],[{"start":42.4,"text":"Boyu, which is co-led by the grandson of former Chinese president Jiang Zemin, is targeting a $6bn fund, according to several people close to the plans. "},{"start":53.329,"text":"Primavera, run by Fred Hu, the former chair for greater China at Goldman Sachs, is raising a fund of up to $5bn, two people close to the group said. "}],[{"start":65.39,"text":"The funds would be the largest and second-largest US dollar funds launched by an independent investment manager in China, according to data provider AVCJ. "}],[{"start":76.77,"text":"FountainVest Partners, which targets China deals and is led by former Goldman Sachs banker Frank Tang, is seeking to raise $3.5bn for a fund, according to two people with knowledge of the plans. "}],[{"start":91.47999999999999,"text":"The flurry of fundraisings comes amid China’s strong economic recovery from Covid-19 and concerns over high valuations in public markets. "}],[{"start":101.74999999999999,"text":"It will also follow similar large-scale moves by regional and global funds focused more widely on Asia this year. "},{"start":109.40399999999998,"text":"Hong Kong-headquartered Baring Private Equity Asia last month opened a fund seeking $8.5bn, while Hillhouse Capital, also based in Hong Kong, is raising what would be Asia’s largest US dollar fund, targeting $13bn. "}],[{"start":126.30999999999999,"text":"US-based KKR on Tuesday announced it had raised $15bn for its fourth Asia-Pacific fund — a record for the region, and exceeding its $12.5bn target. "}],[{"start":139.29,"text":"“Companies across Asia-Pacific are recognising their potential to become not only national and regional champions but also global leaders in their industries,” said Ashish Shastry, KKR co-head of private equity in Asia-Pacific. "}],[{"start":154.39,"text":"One wealthy Asian investor, a member of one of the region’s most influential families, said China’s domestic PE market was developing extremely fast, particularly US dollar funding. "},{"start":166.582,"text":"“[Funds’] bets have begun to show a lot of promise and in many cases, success,” the person said. "}],[{"start":174.35,"text":"The fundraisings were also a sign of the appetite of investors from the US and the Middle East for Chinese companies, particularly in tech and healthcare, according to several people close to the funds. "}],[{"start":186.45,"text":"The deluge of capital focused on China comes despite increased regulatory scrutiny of Chinese technology groups that could dampen the outlook for the sector, as well as an escalating sanctions row between Washington and Beijing. "}],[{"start":200.44,"text":"“We have seen a big increase in allocation in recent months and we saw an unprecedented amount of USD coming into the fund last year,” said the founder of a large Chinese private equity fund. "},{"start":212.682,"text":"“We are expanding fast, we even had to ask some of our investors to cut their subscriptions,” the person added. "}],[{"start":220.72,"text":"The recent surge has more than doubled the average fund size in China to $756m, compared with $415m in 2020, according to data provider Preqin. "},{"start":234.349,"text":"It also bucked the trend of declining capital raising among Asia funds in recent years. "}],[{"start":240.36,"text":"Fundraising activity declined for the third consecutive year in 2020, according to a report by consultancy Bain. "},{"start":248.264,"text":"Asia-focused funds raised $90bn in 2020, 64 per cent lower than a peak in 2017. "},{"start":256.307,"text":"However, private equity-backed deals in the region rose 19 per cent to a record $185bn in 2020, according to Bain. "}],[{"start":267.57,"text":"Boyu and Primavera were both early investors in Jack Ma’s Ant Group and have continued to invest in Chinese tech start-ups. "}],[{"start":275.55,"text":""}]],"url":"https://creatives.ftacademy.cn/album/001092059-1617780215.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

囤积行为加剧伊朗战争引发的经济损害

随着霍尔木兹海峡的对峙进入第三个月,全球各国政府都在艰难应对同一个难题:如何防止囤积者加剧从汽油到注射器等各类产品的短缺。

FT社评:伊朗战争让各国央行进退两难

如果各国央行过早通过加息来遏制通胀压力,可能令本已受创的经济雪上加霜;如但果按兵不动、观望冲突的进展,又可能贻误时机。

反弹的通胀与不耐烦的特朗普:凯文•沃什面临双重压力

美国参议院本周有望批准这位56岁的金融家接替杰伊•鲍威尔出任美联储主席。

伊朗战争推高燃气价格,印度工人纷纷逃离城市生活

伊朗战争推高了烹饪燃料价格,迫使印度许多务工人员返乡回村。

能源、军火与粮食:特朗普对伊战争日益沉重的代价

这场冲突正波及整个美国经济,造成了数千亿美元的产出损失。

肺纤维化生物科技公司Avalyn Pharma申请首次公开募股(IPO)

一家生物技术公司正开发可吸入剂型的已获批肺纤维化口服药,计划赴公开市场融资以支持其后期研发。
2天前
设置字号×
最小
较小
默认
较大
最大
分享×